SBI Securities’s Evogene EVGN Stock Holding History

SBI Securities’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27	Sell	62 -10	-14%	-$7	﹤0.01%	3786
2026 Q1	$55	Hold	72	–	–	﹤0.01%	3554
2025 Q4	$79	Sell	72 -597	-89%	-$697	﹤0.01%	3479
2025 Q3	$764	Hold	669	–	–	﹤0.01%	2805
2025 Q2	$856	Buy	669 +597	+829%	+$730	﹤0.01%	2749
2025 Q1	$90	Hold	72	–	–	﹤0.01%	3476
2024 Q4	$135	Buy	+72	New	+$142	﹤0.01%	3371

SBI Securities's EVGN Position: Q2 2026 in Review

SBI Securities reduced its Evogene (EVGN) stake by 14% in Q2 2026, selling an estimated $7 and leaving 62 shares worth $27. The position accounts for ﹤0.01% of the portfolio, ranked #3786.

SBI Securities first reported a position in EVGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $856 in Q2 2025. 1 fund tracked by Wall St. Rank holds EVGN as of Q2 2026.

SBI Securities held 62 shares of Evogene worth $27 as of Q2 2026.
SBI Securities sold 10 Evogene shares in Q2 2026, an estimated $7.
Evogene made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3786 holding.
SBI Securities first reported a position in Evogene in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Evogene position peaked at $856 in Q2 2025.
1 fund tracked by Wall St. Rank held Evogene as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.